ALTO NEUROSCIENCE INC (ANRO) Stock Analyst Ratings
USA - NYSE:ANRO - US02157Q1094 - Common Stock
10.85 USD
-0.15 (-1.36%)
10.92 USD
+0.07 (+0.65%)
ChartMill assigns a Buy % Consensus number of 85% to ANRO. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 10.54. This target is -2.86% below the current price.
ANRO was analyzed by 15 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about ANRO.
In the previous month the buy percentage consensus was at a similar level.
ANRO was analyzed by 15 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-20 | Baird | Maintains | Outperform -> Outperform |
| 2025-09-29 | Chardan Capital | Initiate | Buy |
| 2025-08-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-06-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-05-15 | Wedbush | Reiterate | Neutral -> Neutral |
| 2025-04-07 | HC Wainwright & Co. | Initiate | Buy |
| 2024-12-16 | Jones Trading | Initiate | Buy |
| 2024-11-13 | Stifel | Maintains | Buy -> Buy |
| 2024-10-23 | Wedbush | Downgrade | Outperform -> Neutral |
| 2024-10-23 | Baird | Maintains | Outperform -> Outperform |
| 2024-09-10 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-09-03 | Wedbush | Initiate | Outperform |
| 2024-06-21 | Rodman & Renshaw | Initiate | Buy |
| 2024-03-25 | Stifel | Reiterate | Buy -> Buy |
| 2024-02-27 | Stifel | Initiate | Buy |
| 2024-02-27 | Baird | Initiate | Outperform |
| 2024-02-27 | Jefferies | Initiate | Buy |